BioCryst Pharmaceuticals, Inc.

BCRXNASDAQHealthcare● Active

$8.32

$-0.09(-1.08%)

Market Cap$1.7B

P/E Ratio—

52W High$11.23

52W Low$6

Avg Volume5.3M

Open$8.43

Beta0.56

Employees Ownership Insider Trades

BioCryst Pharmaceuticals, Inc. (BCRX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · BCRX · as of Feb 26, 2026

Latest filing snapshot

435

-145-25.00%vs prior year

BioCryst Pharmaceuticals, Inc. (BCRX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

435

Change (1Y)

-145

Growth % (1Y)

-25.00%

Revenue / Employee

$2.01M

Net Income / Employee

$606.6K

Market Cap

$1.7B

BCRX Employee Count

1996 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-26	2025-12-31	435	-145	-25.00%
2025-02-25	2024-12-31	580	+44	+8.21%
2024-02-27	2023-12-31	536	+5	+0.94%
2023-02-27	2022-12-31	531	+173	+48.32%
2022-02-28	2021-12-31	358	+112	+45.53%
2021-03-01	2020-12-31	246	+106	+75.71%
2020-03-13	2019-12-31	140	+40	+40.00%
2019-03-14	2018-12-31	100	+15	+17.65%
2018-03-12	2017-12-31	85	+20	+30.77%
2017-02-27	2016-12-31	65	-5	-7.14%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

BCRX

BioCryst Pharmaceuticals, Inc.YOU

435$1.7B #2

NTLA

Intellia Therapeutics, Inc.

Stoke Therapeutics, Inc.

128$1.8B #5

MAZE

Maze Therapeutics, Inc.

Spyre Therapeutics, Inc.

73$4.3B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · BCRX peer comparison

About BCRX employees

BCRX Employees · Headcount

BioCryst Pharmaceuticals, Inc. (BCRX) employee data is sourced from the annual SEC 10-K filing. As of 2025, BioCryst Pharmaceuticals, Inc. had 435 full-time employees globally. Full-time employees only. Global consolidated headcount.

BioCryst Pharmaceuticals, Inc. employs 435 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $2.01M, reflecting the company's operational efficiency.

BioCryst Pharmaceuticals, Inc.'s workforce decreased by 145 (25.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

BioCryst Pharmaceuticals, Inc.'s revenue per employee of $2.01M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

BCRX Employees · 5 questions

As of the latest SEC 10-K filing (2025), BioCryst Pharmaceuticals, Inc. had 435 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

BioCryst Pharmaceuticals, Inc. employee counthow many employees does BioCryst Pharmaceuticals, Inc. haveBCRX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26